• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境友好的不对称脲的合成及其通过计算方法评估作为潜在的 HIV-1 蛋白酶抑制剂。

Environmentally benign synthesis of unsymmetrical ureas and their evaluation as potential HIV-1 protease inhibitors via a computational approach.

机构信息

Department of Environmental Science, Nagaland University, Lumami, Nagaland, 798627, India.

Department of Chemistry, Nagaland University, Lumami, Nagaland, 798627, India.

出版信息

Mol Divers. 2024 Apr;28(2):749-763. doi: 10.1007/s11030-023-10615-9. Epub 2023 Feb 15.

DOI:10.1007/s11030-023-10615-9
PMID:36788191
Abstract

The present work reports the cost-effective, high yielding and environmentally acceptable preparation of unsymmetrical ureas from thiocarbamate salts using sodium percarbonate as an oxidant. Efficacy of the unsymmetrical ureas as potential human immune deficiency virus (HIV-1) protease inhibitors has been evaluated via in silico approach. The results revealed interactions of the urea compounds at the active site of the enzyme with favorable binding affinities causing possible mutations hindering the functioning of the enzyme. Further computational assessment of IC50 using known references satisfactorily authenticated the inhibitory action of the selected compounds against HIV-1 protease. Added to the easy synthesis of the ureas following an environmentally benign protocol, this work may be a valuable addition to the ongoing search for drugs with better efficacy profiles and reduced toxicity against HIV.

摘要

本工作报道了一种经济有效、产率高且环境友好的方法,即用过碳酸钠作为氧化剂,从硫代氨基甲酸酯盐制备不对称脲。通过计算方法评估了不对称脲作为潜在的人类免疫缺陷病毒(HIV-1)蛋白酶抑制剂的功效。结果表明,脲化合物在酶的活性部位发生相互作用,具有有利的结合亲和力,导致可能的突变,从而阻碍酶的功能。进一步使用已知参考物对 IC50 进行计算评估,令人满意地证实了所选化合物对 HIV-1 蛋白酶的抑制作用。除了采用环境友好的方案易于合成脲之外,这项工作可能是对正在进行的寻找具有更好功效谱和降低 HIV 毒性的药物的有价值的补充。

相似文献

1
Environmentally benign synthesis of unsymmetrical ureas and their evaluation as potential HIV-1 protease inhibitors via a computational approach.环境友好的不对称脲的合成及其通过计算方法评估作为潜在的 HIV-1 蛋白酶抑制剂。
Mol Divers. 2024 Apr;28(2):749-763. doi: 10.1007/s11030-023-10615-9. Epub 2023 Feb 15.
2
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors.作为HIV蛋白酶抑制剂的对称和不对称P1/P1'环脲的合成。
Bioorg Med Chem Lett. 1998 May 5;8(9):1077-82. doi: 10.1016/s0960-894x(98)00175-9.
3
Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C-Symmetric HIV-1 Protease Inhibitors and Docking Study.作为C对称HIV-1蛋白酶抑制剂的3,9-二氧杂四萜烷的合成与生物学评价及对接研究
Biol Pharm Bull. 2019;42(2):261-267. doi: 10.1248/bpb.b18-00705.
4
Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups.具有3-氨基吲唑P2/P2'基团的强效环脲HIV蛋白酶抑制剂。
Bioorg Med Chem Lett. 1998 Apr 7;8(7):715-20. doi: 10.1016/s0960-894x(98)00118-8.
5
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.环状脲类作为HIV蛋白酶抑制剂的合成与评价:P1/P1'残基的修饰
Bioorg Med Chem Lett. 1998 Apr 7;8(7):823-8. doi: 10.1016/s0960-894x(98)00119-x.
6
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituents.作为HIV-1蛋白酶抑制剂的不对称环状脲:作为P2/P2'取代基的新型联芳基吲唑
Bioorg Med Chem Lett. 1999 Nov 15;9(22):3217-20. doi: 10.1016/s0960-894x(99)00564-8.
7
Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.HIV-1天冬氨酸蛋白酶非对称环状脲抑制剂的组合设计
Bioorg Med Chem. 2005 Sep 15;13(18):5492-501. doi: 10.1016/j.bmc.2005.06.026.
8
Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.整合多种受体构象对接和多维定量构效关系以提高结合亲和力预测的准确性。
Curr Comput Aided Drug Des. 2017;13(2):127-142. doi: 10.2174/1573409913666170119115841.
9
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.作为HIV-1蛋白酶抑制剂的非肽环氰基胍:合成、构效关系及X射线晶体结构研究
J Med Chem. 1998 Apr 23;41(9):1446-55. doi: 10.1021/jm970524i.
10
Tricyclic ureas: a new class of HIV-1 protease inhibitors.三环脲类:一类新型的HIV-1蛋白酶抑制剂。
Bioorg Med Chem Lett. 1998 Dec 15;8(24):3615-20. doi: 10.1016/s0960-894x(98)00659-3.

本文引用的文献

1
A PANI-FeO@ZnO nanocomposite: a magnetically separable and applicable catalyst for the synthesis of chromeno-pyrido[]pyrimidine derivatives.聚苯胺-氧化铁@氧化锌纳米复合材料:一种用于合成色烯并吡啶[]嘧啶衍生物的可磁分离且适用的催化剂。
RSC Adv. 2020 Apr 21;10(26):15614-15621. doi: 10.1039/d0ra01978j. eCollection 2020 Apr 16.
2
Synthesis, structural elucidation, DFT calculation, biological studies and DNA interaction of some aryl hydrazone Cr, Fe, and Cu chelates.一些芳基腙铬、铁和铜配合物的合成、结构阐明、DFT 计算、生物研究和 DNA 相互作用。
Comput Biol Chem. 2022 Apr;97:107643. doi: 10.1016/j.compbiolchem.2022.107643. Epub 2022 Feb 11.
3
Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.
含三唑连接基团的尿素-噻唑/苯并噻唑杂合体:合成、抗菌潜力、药代动力学特征和计算机机制研究。
Mol Divers. 2022 Oct;26(5):2375-2391. doi: 10.1007/s11030-021-10336-x. Epub 2021 Oct 20.
4
Bioisosteric Replacement as a Tool in Anti-HIV Drug Design.生物电子等排体替代作为抗HIV药物设计的一种工具
Pharmaceuticals (Basel). 2020 Feb 28;13(3):36. doi: 10.3390/ph13030036.
5
Identification and molecular modeling of new quinolin-2-one thiosemicarbazide scaffold with antimicrobial urease inhibitory activity.鉴定并建立新型喹啉-2-酮缩氨硫脲骨架的分子模型,该骨架具有抗微生物脲酶抑制活性。
Mol Divers. 2021 Feb;25(1):13-27. doi: 10.1007/s11030-019-10021-0. Epub 2020 Jan 8.
6
Synthesis, Evaluation, Molecular Docking and DFT Studies of Some Phenyl Isothiocyanates as Anticancer Agents.苯基异硫氰酸酯类化合物的合成、评价、分子对接及 DFT 研究作为抗癌剂。
Anticancer Agents Med Chem. 2019;19(18):2211-2222. doi: 10.2174/1871520619666190930122137.
7
Examining pharmacodynamic and pharmacokinetic properties of eleven analogues of saquinavir for HIV protease inhibition.研究沙奎那韦的十一种类似物对HIV蛋白酶抑制的药效学和药代动力学特性。
Arch Virol. 2019 Apr;164(4):949-960. doi: 10.1007/s00705-019-04153-9. Epub 2019 Jan 24.
8
Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives.可扩展的、一锅法、微波加速的不对称脲衍生物的串联合成。
J Org Chem. 2017 Jan 20;82(2):992-999. doi: 10.1021/acs.joc.6b02521. Epub 2016 Dec 30.
9
Identification of non-resistant ROS-1 inhibitors using structure based pharmacophore analysis.使用基于结构的药效团分析鉴定非耐药性ROS-1抑制剂。
J Mol Graph Model. 2016 Nov;70:85-93. doi: 10.1016/j.jmgm.2016.09.013. Epub 2016 Sep 29.
10
Development of Quantum Chemical Method to Calculate Half Maximal Inhibitory Concentration (IC50 ).用于计算半数最大抑制浓度(IC50)的量子化学方法的开发。
Mol Inform. 2016 May;35(5):199-206. doi: 10.1002/minf.201501004. Epub 2016 Mar 8.